Anixa Biosciences, Inc. (ANIX)
3.625
-0.08
(-2.29%)
USD |
NASDAQ |
Aug 24, 16:00
3.62
0.00 (0.00%)
After-Hours: 20:00
Anixa Biosciences Total Liabilities (Quarterly) : 1.641M for April 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | 1.641M |
| January 31, 2026 | 1.387M |
| October 31, 2025 | 2.13M |
| July 31, 2025 | 2.24M |
| April 30, 2025 | 2.071M |
| January 31, 2025 | 2.193M |
| October 31, 2024 | 2.703M |
| July 31, 2024 | 2.217M |
| April 30, 2024 | 1.774M |
| January 31, 2024 | 1.768M |
| October 31, 2023 | 2.151M |
| July 31, 2023 | 1.993M |
| April 30, 2023 | 1.686M |
| January 31, 2023 | 1.394M |
| October 31, 2022 | 2.212M |
| July 31, 2022 | 1.656M |
| April 30, 2022 | 1.391M |
| January 31, 2022 | 1.996M |
| October 31, 2021 | 1.491M |
| July 31, 2021 | 1.208M |
| April 30, 2021 | 1.443M |
| January 31, 2021 | 1.526M |
| October 31, 2020 | 1.189M |
| July 31, 2020 | 1.224M |
| April 30, 2020 | 1.103M |
| Date | Value |
|---|---|
| January 31, 2020 | 1.166M |
| October 31, 2019 | 1.481M |
| July 31, 2019 | 1.444M |
| April 30, 2019 | 1.596M |
| January 31, 2019 | 1.327M |
| October 31, 2018 | 1.265M |
| July 31, 2018 | 1.130M |
| April 30, 2018 | 1.340M |
| January 31, 2018 | 1.087M |
| October 31, 2017 | 0.8895M |
| July 31, 2017 | 2.927M |
| April 30, 2017 | 3.66M |
| January 31, 2017 | 8.037M |
| October 31, 2016 | 4.641M |
| July 31, 2016 | 4.603M |
| April 30, 2016 | 4.646M |
| January 31, 2016 | 5.056M |
| October 31, 2015 | 4.282M |
| July 31, 2015 | 4.282M |
| April 30, 2015 | 4.143M |
| January 31, 2015 | 5.013M |
| October 31, 2014 | 5.046M |
| July 31, 2014 | 13.25M |
| April 30, 2014 | 15.35M |
| January 31, 2014 | 16.00M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Vicapsys Life Sciences, Inc. | 3.682M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.86M |
| Shareholders Equity (Quarterly) | 14.48M |
| Debt to Equity Ratio | 0.0127 |
| Current Ratio | 9.788 |
| Net Debt Paydown Yield | 0.01% |